EUVIMEDEUVIMED entdecken
Crossref

Phillygenin Inhibits TGF-β1-induced Hepatic Stellate Cell Activation and Inflammation: Regulation of the Bax/Bcl-2 and Wnt/β-catenin Pathways

Cheng Wang, Shenglin Zhang, Yanzhi Li, Lihong Gong, Chenhao Yao, Ke Fu, Yunxia Li

Inflammation · 2024

DOI: 10.1007/s10753-024-01984-w ↗

Kurz gefasst

Fachartikel in der Zeitschrift Inflammation, 2024. Verfasst von Cheng Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Southwestern Chinese Medicine Resources, Key Laboratory of Standardization for Chinese Herbal Medicine, Ministry of Education…. Hauptthemen laut MEDLINE: Hepatic Stellate Cells, Transforming Growth Factor beta1, Wnt Signaling Pathway, Lignans. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Sichuan Province Science and Technology Support Program, Sichuan TCM Science and Technology Industry Innovation Team.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatic fibrosis (HF), a precursor to cirrhosis and hepatocellular carcinoma, is caused by abnormal proliferation of connective tissue and excessive accumulation of extracellular matrix in the liver. Notably, activation of hepatic stellate cells (HSCs) is a key link in the development of HF. Phillygenin (PHI, C21H24O6) is a lignan component extracted from the traditional Chinese medicine Forsythiae Fructus, which has various pharmacological activities such as anti-inflammatory, antioxidant and anti-tumour effects. However, whether PHI can directly inhibit HSC activation and ameliorate the mechanism of action of HF has not been fully elucidated. Therefore, the aim of the present study was to investigate the in vitro anti-HF effects of PHI and the underlying molecular mechanisms. Transforming growth factor-β1 (TGF-β1)-activated mouse HSCs (mHSCs) and human HSCs (LX-2 cells) were used as an in vitro model of HF and treated with different concentrations of PHI for 24 h. Subsequently, cell morphological changes were observed under the microscope, cell viability was analyzed by MTT assay, cell cycle and apoptosis were detected by flow cytometry, and the mechanism of anti-fibrotic effect of PHI was explored by immunofluorescence, ELISA, RT-qPCR and western blot. The results showed that PHI suppressed the proliferation of TGF-β1-activated mHSCs and LX-2 cells, arrested the cell cycle at the G0/G1 phase, decreased the levels of α-SMA, Collagen I, TIMP1 and MMP2 genes and proteins, and promoted apoptosis in activated mHSCs and LX-2 cells. Besides, PHI reduced the expression of inflammatory factors in activated mHSCs and LX-2 cells, suggesting a potential anti-inflammatory effect. Mechanically, PHI inhibited TGF-β1-induced HSC activation and inflammation, at least in part through modulation of the Bax/Bcl-2 and Wnt/β-catenin pathways. Overall, PHI has significant anti-HF effects and may be a promising agent for the treatment of HF.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatic Stellate CellsTransforming Growth Factor beta1Wnt Signaling PathwayLignansProto-Oncogene Proteins c-bcl-2bcl-2-Associated X ProteinApoptosisAnimalsHumansMiceInflammationLiver Cirrhosisbeta CateninCell LineAnti-Inflammatory Agents

Stichwörter der Autor:innen

Bax/Bcl-2Wnt/β-cateninhepatic stellate cell activationinflammationphillygenintransforming growth factor-β1

Substanzen

Transforming Growth Factor beta1LignansProto-Oncogene Proteins c-bcl-2bcl-2-Associated X Proteinphillygeninbeta CateninAnti-Inflammatory AgentsBax protein, mouseBcl2 protein, mouse

Autor:innen und Institutionen

  • State Key Laboratory of Southwestern Chinese Medicine Resources, Key Laboratory of Standardization for Chinese Herbal Medicine, Ministry of Education, School of Pharmacy, Chengdu University of Traditional Chinese Medici…

Förderung

  • National Natural Science Foundation of China
  • Sichuan Province Science and Technology Support Program
  • Sichuan TCM Science and Technology Industry Innovation Team
  • Innovation Team and Talents Cultivation Program of National Administration of Traditional Chinese Medicine

Zitieren

APA

Wang, C., Zhang, S., Li, Y., Gong, L., Yao, C., Fu, K., & Li, Y. (2024). Phillygenin Inhibits TGF-β1-induced Hepatic Stellate Cell Activation and Inflammation: Regulation of the Bax/Bcl-2 and Wnt/β-catenin Pathways. Inflammation. https://doi.org/10.1007/s10753-024-01984-w

Vancouver

Wang C, Zhang S, Li Y, Gong L, Yao C, Fu K, et al. Phillygenin Inhibits TGF-β1-induced Hepatic Stellate Cell Activation and Inflammation: Regulation of the Bax/Bcl-2 and Wnt/β-catenin Pathways. Inflammation. 2024. doi:10.1007/s10753-024-01984-w

BibTeX
@article{Wang2024,
  author = {Wang, Cheng and Zhang, Shenglin and Li, Yanzhi and Gong, Lihong and Yao, Chenhao and Fu, Ke and Li, Yunxia},
  title = {Phillygenin Inhibits TGF-β1-induced Hepatic Stellate Cell Activation and Inflammation: Regulation of the Bax/Bcl-2 and Wnt/β-catenin Pathways},
  journal = {Inflammation},
  year = {2024},
  doi = {10.1007/s10753-024-01984-w}
}
Kostenlos starten →